Vienna General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<p>Observing proteins precisely within cells is extremely important for many branches of research but has been a significant technical challenge - especially in living cells, as the required fluorescent labelling had to be individually attached to each protein. The research group led by Stefan Kubicek at CeMM has now overcome this hurdle: With a method called &quot;vpCells,&quot; it is possible to label many proteins simultaneously, using five different fluorescent colours. This automated high-throughput approach, aided by AI-assisted image recognition, opens up entirely new appl...

Vienna researchers reported that 7 of 10 patients treated with systemic sirolimus had noted improvements in skin lesions, which continued for up to 2 years of follow-up.

<p><strong>Bacillus Calmette-Gu&eacute;rin (BCG) is one of the world&rsquo;s oldest and most widely used vaccines. It was developed in the early 20^th century to provide protection from tuberculosis. Surprisingly, this vaccine protects not only against tuberculosis but also reduces the risk for various other infections, through a mechanism called trained immunity. A new study led by Christoph Bock and Mihai Netea found that epigenetic cell states predict whether or not an individual profits from the &ldquo;wake-up call&rdquo; to the innate immu...

Scientists from the Giulio Superti-Furga Lab at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, have developed a new method that allows the discovery of specific inhibitors of a lactate transporter associated with cancer and other disease areas. The compound identified in the assay system could provide a new starting point for cancer treatments. The study has now been published in Cell Chemical Biology.

The government is intent on improving the performance of the healthcare system, said the State Secretary at the Semmelweis Day Award Ceremony.